LT - RET inhibitorius, skirtas naudoti vėžiui gydyti, esant RET pakitimui
EN - RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/506 |
(2006.01) |
|
|
A61K 45/06 |
(2006.01) |
|
|
A61P 35/04 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3773589 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
19718531.7 |
|
Date of filing the European patent application |
2019-04-03 |
| (97) |
Date of publication of the European application |
2021-02-17 |
| (45) |
Date of publication and mention of the grant of the patent |
2023-11-01
|
| (46) |
Date of publication of the claims translation |
2024-02-12
|
PCT application
| (86) |
Number |
PCT/US2019/025655 |
|
Date |
2019-04-03 |
PCT application publication
| (87) |
Number |
WO 2019/195471 |
|
Date |
2019-10-10 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201862652284 P |
2018-04-03
|
US |
|
201862656297 P |
2018-04-11
|
US |
|
201862657605 P |
2018-04-13
|
US |
|
201862741683 P |
2018-10-05
|
US |
Inventors
| (72) |
EVANS RAAB, Erica , US
WOLF, Beni B. , US
|
Grantee
| (73) |
Blueprint Medicines Corporation ,
45 Sidney Street, Cambridge, MA 02139,
US
|
Attorney or representative
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
Title
| (54) |
RET inhibitorius, skirtas naudoti vėžiui gydyti, esant RET pakitimui |
| |
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-03-05 |
7 |
162.00
EUR
|
Next renewal fee
|
2026-04-03 |
